Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACT| |GGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTC
End
194765430/193900706 (Hg38)
Nearest miRNA
hsa-mir-10b/Upstream/4767595; hsa-mir-1244-1/Downstream/12882528;
Upstream sequence
GGAACTACTTTGATGatatatatatatatatgagatatatctcatatatatatataGTTCCCCCCCCCCCCCAAGAGATTCATTAAGGCATCCTTGTACC
Downstream sequence
TGTTTAACTTTCCTTGGAACAAGAATTGTTGATTGTGATGTAGAGGTAACCTATCTAGCAGTGTAGGGGCTATTTATGTGTGCCTATTTTAATttaagta
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.